Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced a strategic ...
A research team led by Prof. TAN Weihong and Prof. WU Qin from the Hangzhou Institute of Medicine (HIM) of the Chinese Academy of Sciences has developed a pioneering, multi-modal platform called SPARK ...
The meninges act as a key mechano-biological interface—dissipating external forces, supporting neuroimmune homeostasis, and dynamically regulating the ...
News-Medical.Net on MSN
Single-cell analysis illuminates myeloma immune landscape
Scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research Foundation (MMRF ...
TipRanks on MSN
2 new IPO stocks enter the fray; JP Morgan says 'buy'
In this past year, we’ve seen the IPO market stabilize after several years of large-scale uncertainties – think post-COVID ...
A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled “A ...
News-Medical.Net on MSN
RNA splicing and processing genes emerge as central drivers of aging across tissues
A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled "A ...
Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback